15.11.2017 • News

Lanxess to Buy Solvay's US Phosphorus Additives Business

In a move to expand its additives portfolio, Germany’s Lanxess has clinched a deal with Solvay to acquire the Belgian chemical producer’s US phosphorus chemicals business based at Charleston, South Carolina. Anno Borkowsky, general manager of the additives business unit, said the buy will help the company to “further drive our growth in this key region."

The deal is planned to close in the first half of next year, subject to customary regulatory approvals. Lanxess said the acquisition fully complements its strategy to grow its business in mid-sized markets and in the regions North America and Asia.

With the takeover, which will add €65 million in sales to the €2 billion of its own additives slate, the German specialty chemicals producer will gain six production units and roughly 90 employees to complement its own 2,000-member additives staff. Along with phosphorus chloride, the Solvay plant produces derivatives such as flame retardants, plastics additives and intermediates for the agrochemical industry.

For Solvay, Michael Radossich, president of the Technology Solutions global business unit, said the divestment will strengthen the company’s focus and allow it to concentrate its resources on its existing leadership positions in phosphine gas, phosphine derivatives and phosphorous specialties.

In Lanxess, Radossich said, Solvay’s Charleston employees and customers “will have a buyer with a strategic, geographic and technical fit to expand the business and its offerings.”

Company

Logo:

LANXESS Deutschland GmbH

Kennedyplatz 1
50569 Köln
Germany

Company contact







Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.